Results 141 to 150 of about 7,093,593 (187)

Standard Methods for Quality Control in Cell-Based Medicinal Products and their Validation for Clinical Applications. [PDF]

Adv Biomed Res
Mahmoodi Khaledi E, Samadian A, Sabahi Moosavi N, Dashtbozorgi S, Foroughian S, Rismani E, Hajizadeh-Saffar E, Vosough M.   +7 more
europepmc   +1 more source

The polymeric nanovectors landscape for cancer immunotherapies towards advanced therapy medicinal products (ATMPs)

Acta Pharmaceutica Sinica B
Ilaria Elena Palamà, Alessandra Invidia, Claudia De Stradis, Gabriella Leccese, Clara Baldari, Barbara Cortese, Clara Guido, Andrea Giglio, Concetta Quintarelli, Biagio De Angelis, Gabriele Maiorano, Franco Locatelli, Giuseppe Gigli   +12 more
openaire   +1 more source

Trends in EU regulatory assessment of oncology medicines. [PDF]

ESMO Open
Pabsch T, Pignatti F, Day F, Sepodes B, Enzmann H.   +4 more
europepmc   +1 more source

Designs of the clinical trials aiming at evaluating cell and gene therapy products: A critical appraisal from a literature review. [PDF]

Mol Ther Adv
Biard L, Lévy V, Chevret S, JOIN4ATMP consortium.   +3 more
europepmc   +1 more source

Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest link. [PDF]

Bone Marrow Transplant
Chartral U, Galaine J, Giverne C, Auxenfans C, Reppel L, Marton C, Thiant S, Clémenceau B, Derenne S, Sabatier F, Veran J, Moisan A, Rouard H, Tertrais K, Dachy G, Demerle C, Calmels B, Chabannon C, Forcade E, Viel S, Bensoussan D, de Vos J, Galy A, De Oliveira C, Boucher H, Magrin E, Fabreguettes JR, Cavazzana M, Larghero J, Deschamps M, Martinet J, Boyer O, Ferrand C, Yakoub-Agha I, Diana JS.   +34 more
europepmc   +1 more source

Vulnerability, protection and fairness: ethical and regulatory limits in small-N gene therapy trials. [PDF]

Trials
Reckelbus M, Van Steijvoort E, Huys I, Borry P.   +3 more
europepmc   +1 more source

Reimbursement routes and past practices for advanced therapy medicinal products in the Netherlands. [PDF]

Regen Med
Gort J, van Hattem CC, Logman F, Frederix GWJ, Hooft L, Bloem LT, Ten Ham RMT.   +6 more
europepmc   +1 more source

Clarifying the critical differences between the enzymatic stromal vascular fraction and the mechanically derived stromal vascular tissue or nanofat for spinal cord injury applications. [PDF]

Stem Cell Res Ther
Nonnarath C, Serratrice N.
europepmc   +1 more source

Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China. [PDF]

Regen Ther
Shi J, Hu H, Ung COL.
europepmc   +1 more source

Developing and validating a regulatory science competency framework for immune cell therapy: a mixed-methods study. [PDF]

Front Med (Lausanne)
Lee JA.
europepmc   +1 more source